You are using a version of the website built for webcrawlers and people whose devices cannot use javascript.
Some functionality will not be available.
Warning: This page is an archive.
General administrative information and links are not current and should not be used.
Contents (2008 - 392)
Poisons and Therapeutic Goods Regulation 2008
Current version for 1 July 2017 to date (accessed 18 November 2017 at 06:26)
93   Exemptions relating to methadone or buprenorphine supply at pharmacies
(1)  The owner of a pharmacy may apply in writing to the Director-General for an exemption from clause 92 (1A) or (1) in relation to the pharmacy.
(2)  The Director-General may require the owner of the pharmacy to furnish such information as is necessary to enable the Director-General to determine the application.
(3)  The Director-General may, by notice in writing served on the owner of the pharmacy, grant the exemption, if the Director-General is satisfied that exceptional circumstances exist that justify the granting of the exemption, or refuse to grant the exemption.
(4)  An exemption is subject to such conditions as may be specified in the notice referred to in subclause (3) and to such further conditions as the Director-General may from time to time notify in writing to the holder of the exemption.
(5)  The Director-General may from time to time vary or revoke any condition of an exemption by notice in writing served on the holder of the exemption.
(6)  An exemption remains in force until:
(a)  the expiry date (if any) specified in the exemption, or
(b)  it is surrendered or cancelled,
whichever occurs first.
(7)  The Director-General may suspend or cancel an exemption by notice in writing served on the holder of the exemption.
(8)  An exemption has no effect during any period of suspension.
(9)  For the removal of doubt, an exemption is not a licence or authority for the purposes of this Regulation.